《全日總結》恆指升507點 科技股彈 吉利揚逾半成
美聯儲局主席鮑威爾放「鴿」指不會因擔心可能出現通脹而先發制人地加息。美國股市昨晚(22日)造好,納指創收市新高升0.8%。港股隨外圍向好,恆指今早高開158點後升勢持續,午後愈升愈有,最多升584點一度高見28,893點,全日升507點或1.8%,報28,817點;國指升204點或2%,報10,673點。恆生科技指數升208點或2.7%,報8,020點。港股全日成交1,565.61億元。滬、深港通南下交易全日分別錄得淨流入8.08億元及11.32億元人民幣。
科技股表現向好,美團(03690.HK)重上300元關,收升5.2%報308元;騰訊(00700.HK)升1.6%報582.5元。舜宇光學(02382.HK)更升7%,銀河-聯昌證券引述舜宇管理層料受惠行業發展,料車載鏡頭業務增長將加快;小米(01810.HK)、阿裏巴巴(09988.HK)及京東(09618.HK)分別升1.5%、2.1%及2.6%。
部分汽車股急升,吉利汽車(00175.HK)全日彈高5.8%,比亞迪(01211.HK)亦升3%;長城汽車(02333.HK)升6.1%,券商大和引述長汽指內地政府投放原料國儲助成本回穩,料盈利能力好轉。東風集團(00489.HK)及五菱汽車(00305.HK)升0.7%及1.1%。
友邦保險(01299.HK)獲批開始籌建湖北分公司,收升3%。匯控(00005.HK)微升0.7%造46.05元。港交所(00388.HK)升1.6%。中移動(00941.HK)跌0.6%。
內銀股靠穩,國壽(02628.HK)、工行(01398.HK)、建行(00939.HK)升1%、0.4%及0.5%。中石油(00857.HK)續升2.5%。
內地將新冠疫苗產品列入可供對外出口新冠病毒疫苗產品清單,生物科技股造好,康希諾(06185.HK)今早漲逾一成後中途停牌,下午復牌,全日收升12.4%;藥明生物(02269.HK)升2.9%,康龍化成(03759.HK)升1.8%,德琪醫藥(06996.HK)飆17.9%。
體育用品股續升,安踏體育(02020.HK)及特步(01368.HK)股價分別升3.2%及4.2%,李寧(02331.HK)亦升2.7%。
火鍋股逆市下跌,海底撈(06862.HK)及呷哺呷哺(00520.HK)均跌1.7%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.